Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Pharmacy students help boost research to ease eye problems associated with cystinosis

Three final-year pharmacy students from the University of Sunderland who helped test a range of drugs to treat eye problems in patients suffering from a rare genetic disease have showcased their results at an international conference.

Front row: pharmacy students Marina Mankarous, Chloe Auckland and Chee Khaw

Front row (left to right): pharmacy students Marina Mankarous, Chloe Auckland and Chee Khaw

Chee Khaw, Marina Mankarous and Chloe Auckland assisted PhD student Lisa Frost in investigating eye problems associated with cystinosis, a disease that occurs when the body’s mechanism to remove the amino acid cysteine breaks down. If left untreated, the inherited illness can result in kidney failure before a child reaches the age of 10. One of the effects of the disease is the build up of cysteine crystals in the eyes, which causes pain, discomfort and photophobia.

The research was showcased at the Cystinosis Research Network (CRN) international conference in San Francisco in July and, recently, at the UK’s CRN conference, alongside work pharmaceutical scientists are carrying out at Sunderland to improve drug treatment and to learn more about the disease.

Roz Anderson, professor of pharmaceutical chemistry at Sunderland, who is leading the research, said: “[Patients who have cystinosis] often have to endure eye drops every hour, which stings. The effects also do not last very long. The current medication oxidises very quickly, even if it’s stored in the fridge, [so] it’s not very efficient.”

“Lisa has designed and made some prodrugs for ocular use and the three students have been looking at different aspects of those drugs, helping us to select which ones have the best properties that we can take forward for clinical trials,” she added.

Ms Mankarous, from Canada, has been screening the drugs for toxicity; Mr Khaw, from Malaysia, has been investigating their absorption properties; and Ms Auckland, from Barnsley, has been assessing the stability of the drugs under different conditions.


Citation: Tomorrow's Pharmacist URI: 11087397

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • Front row: pharmacy students Marina Mankarous, Chloe Auckland and Chee Khaw

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.